Shah, M., Grothey, A., Tebbutt, N., Xu, R., Yoshino, T., Cervantes, A., Tabernero, J., Taieb, J., Falcone, A., Xu, B., Fontaine, M., Borodyansky, L., & Van Cutsem, E. (n.d.). p-297CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095519247.0x000032